Q BioMed Inc.

CIK 1596062 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Q BioMed Inc..

Recent SEC filings

FiledFormAccession number
Apr 2, 2026REVOKED9999999997-26-000610
Nov 4, 2024SC 13G/A0001104659-24-113973
Jun 23, 202310-Q/A0001410578-23-001458
Jun 16, 20238-K0001104659-23-072297
Jun 16, 202310-Q0001410578-23-001445
May 26, 20238-K0001104659-23-065537
May 26, 202310-K0001410578-23-001376
Mar 1, 2023NT 10-K0001104659-23-027193
Jan 3, 2023SC 13G/A0001104659-23-000316
Dec 7, 2022DEF 14C0001104659-22-125148
Nov 18, 2022PRE 14C0001104659-22-120384
Nov 18, 20228-K0001104659-22-120386
Nov 3, 202210-Q0001410578-22-002927
Oct 17, 2022NT 10-Q0001104659-22-109379
Oct 6, 2022RW0001104659-22-106657
Jul 28, 202210-Q0001410578-22-001992
Jul 15, 2022NT 10-Q0001104659-22-080249
Jun 1, 2022SC 13G/A0001104659-22-067068
May 31, 202240001104659-22-066485
May 31, 202240001104659-22-066487
May 13, 20228-K0001104659-22-060388
Apr 14, 202210-Q0001410578-22-000915
Feb 28, 202210-K0001410578-22-000230
Jan 25, 20228-K0001104659-22-007252
Jan 11, 2022SC 13G/A0001104659-22-003202